Guillermo Villa

1.5k total citations
81 papers, 1.0k citations indexed

About

Guillermo Villa is a scholar working on Economics and Econometrics, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Guillermo Villa has authored 81 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Economics and Econometrics, 35 papers in Surgery and 14 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Guillermo Villa's work include Health Systems, Economic Evaluations, Quality of Life (39 papers), Lipoproteins and Cardiovascular Health (35 papers) and Pharmaceutical Economics and Policy (19 papers). Guillermo Villa is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (39 papers), Lipoproteins and Cardiovascular Health (35 papers) and Pharmaceutical Economics and Policy (19 papers). Guillermo Villa collaborates with scholars based in Switzerland, United States and United Kingdom. Guillermo Villa's co-authors include Peter Lindgren, Ben van Hout, Gregg C. Fonarow, Yi Qian, Ransi Somaratne, Pablo Rebollo, Mickael Löthgren, Jesús Cuervo, Jorge Arellano and Sandhya Sapra and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and European Heart Journal.

In The Last Decade

Guillermo Villa

74 papers receiving 1000 citations

Peers

Guillermo Villa
Lucie Kutikova Switzerland
E. Alemao United States
Iacopo Cricelli Italy
Kristen Migliaccio–Walle United States
Sumesh Kachroo United States
Shahnaz Khan United States
Christopher Dudley United Kingdom
James D. Chambers United States
Jennifer Sung United States
N. Muszbek United Kingdom
Lucie Kutikova Switzerland
Guillermo Villa
Citations per year, relative to Guillermo Villa Guillermo Villa (= 1×) peers Lucie Kutikova

Countries citing papers authored by Guillermo Villa

Since Specialization
Citations

This map shows the geographic impact of Guillermo Villa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guillermo Villa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guillermo Villa more than expected).

Fields of papers citing papers by Guillermo Villa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guillermo Villa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guillermo Villa. The network helps show where Guillermo Villa may publish in the future.

Co-authorship network of co-authors of Guillermo Villa

This figure shows the co-authorship network connecting the top 25 collaborators of Guillermo Villa. A scholar is included among the top collaborators of Guillermo Villa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guillermo Villa. Guillermo Villa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Villa, Guillermo, Maarten J. Postma, Eduard Sidelnikov, et al.. (2020). PCV57 A Systematic Literature Review of Cost-Utility Analyses of PCSK9 Inhibitors. Value in Health. 23. S497–S497.
3.
Pemberton‐Ross, Peter, et al.. (2019). PCV60 BURDEN OF CARDIOVASCULAR DISEASE AND POTENTIAL IMPACT OF PCSK9I IN THE PREVENTION OF CARDIOVASCULAR EVENTS IN SWITZERLAND. Value in Health. 22. S552–S552. 1 indexed citations
4.
Lindgren, Peter, Emil Hagström, Guillermo Villa, et al.. (2019). PCV40 COST-EFFECTIVENESS OF EVOLOCUMAB IN ATHEROSCLEROTIC CARDIOVASCULAR DISEASE PATIENTS WITH VARYING RISK PROFILES IN SWEDEN. Value in Health. 22. S548–S548. 1 indexed citations
5.
Lipton, RB, et al.. (2018). Estimating Patient Utility in Migraine: Longitudinal Analysis of Erenumab Clinical Trial Data. Value in Health. 21. S225–S225. 1 indexed citations
6.
Villa, Guillermo, et al.. (2017). Risk Adjustments In Economic Models - What Is Their Impact On Predicted Rates?. Value in Health. 20(9). A753–A754. 1 indexed citations
7.
Kruse, Gregory, Lucie Kutikova, Bruce Wong, et al.. (2017). Cardiovascular Disease Risk And Risk Factors Associated With Familial Hypercholesterolemia: A Systematic Review. Value in Health. 20(9). A606–A606. 4 indexed citations
8.
Villa, Guillermo, et al.. (2016). Uso de técnicas de estimación en el cálculo de la duración de proyectos de TIC en Uruguay. SHILAP Revista de lepidopterología. 2 indexed citations
9.
Li, Xiaoyan, Michael Maschio, Guillermo Villa, et al.. (2016). Cost-Effectiveness Analysis of Prophylaxis Treatment Strategies to Reduce the Incidence of Febrile Neutropenia in Patients with Early-Stage Breast Cancer or Non-Hodgkin Lymphoma. PharmacoEconomics. 35(4). 425–438. 24 indexed citations
10.
Almeida, N., et al.. (2016). SenSyF Experience on Integration of EO Services in a Generic, Cloud-Based EO Exploitation Platform. 740. 26. 1 indexed citations
11.
Villa, Guillermo, Mickael Löthgren, Lucie Kutikova, et al.. (2016). Cost-Effectiveness of Evolocumab in Patients with High Cardiovascular Risk in Spain. Value in Health. 19(7). A651–A652. 2 indexed citations
12.
Quek, Ruben G.W., Guillermo Villa, Shravanthi R. Gandra, et al.. (2016). A Systematic Review of Cardiovascular Outcomes-Based Cost-Effectiveness Analyses of Lipid-Lowering Therapies. PharmacoEconomics. 35(3). 297–318. 13 indexed citations
13.
Wong, Bruce, Guillermo Villa, Lucie Kutikova, et al.. (2015). The Magnitude of Increased Cardiovascular (Cv) Risk Associated with Familial Hypercholesterolemia (Fh) for use in Economic Analyses. Value in Health. 18(7). A340–A340. 2 indexed citations
14.
15.
16.
17.
Scaturro, Maria, Stefano Fontana, Stefano Crippa, et al.. (2014). An unusually long-lasting outbreak of community-acquired Legionnaires' disease, 2005–2008, Italy. Epidemiology and Infection. 143(11). 2416–2425. 15 indexed citations
18.
Villa, Guillermo, et al.. (2014). Ldl-C Lowering Efficacy of Evolocumab (Amg 145) Could Reduce Apheresis in Patients At High Risk for Cardiovascular Events in Germany. Value in Health. 17(7). A504–A505. 1 indexed citations
19.
Montejo, Ángel L., et al.. (2011). Estimation of a Multiattribute Utility Function for the Spanish Version of the TooL Questionnaire. Value in Health. 14(4). 564–570. 11 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lucie Kutikova Breakdown of academic impact, for papers by E. Alemao Breakdown of academic impact, for papers by Iacopo Cricelli Breakdown of academic impact, for papers by Kristen Migliaccio–Walle Breakdown of academic impact, for papers by Sumesh Kachroo Breakdown of academic impact, for papers by Shahnaz Khan Breakdown of academic impact, for papers by Christopher Dudley Breakdown of academic impact, for papers by James D. Chambers Breakdown of academic impact, for papers by Jennifer Sung Breakdown of academic impact, for papers by N. Muszbek
Rankless by CCL
2026